Skip to main content

Advertisement

Table 1 General characteristics and anthropometric variables in treatment groups before and after intervention

From: The effects of Nigella sativa on thyroid function, serum Vascular Endothelial Growth Factor (VEGF) – 1, Nesfatin-1 and anthropometric features in patients with Hashimoto’s thyroiditis: a randomized controlled trial

N Nigella sativa Placebo P
N = 20 N = 20
Age (years) 35.70 ± 8.18 33.95 ± 8.72 0.52
Levothyroxine (mcg/d) 119.85 ± 24.12 118.46 ± 22.12 0.91
Female [n (%)] 17 (85) 17 (85) 0.89
Weight (kg)
 Before 70.52 ± 12.27 69.63 ± 11.75 0.81
 After 69.39 11.84 69.62 11.80 0.95
P 0.004 0.91  
BMI (kg/m2)
 Before 27.10 ± 4.63 25.93 ± 4.07 0.40
 After 26.63 4.42 25.95 4.11 0.61
P 0.002 0.65  
Waist Circumference (cm)
 Before 88.56 ± 7.29 88.69 ± 7.41 0.95
 After 87.72 ± 6.92 88.57 ± 7.35 0.71
P 0.006 0.17  
HC (cm)
 Before 102.85 ± 6.25 101.77 ± 6.84 0.61
 After 101.56 ± 5.51 101.56 ± 7.02 0.99
P 0.001 0.08  
WHR
 Before 0.86 ± 0.052 0.87 ± 0.053 0.53
 After 0.86 ± 0.05 0.87 ± 4.11 0.61
P 0.38 0.53  
  1. BMI body mass index, WC waist circumference, HC hip circumference, WHR waist to hip ratio, †P values for ANOCOVA after adjustment for age, gender, duration of the disease and variable’s baseline value; ‡P values for paired t-test. Data are presented as mean ± SD or number (percent), the bolded P values are statistically significant